Clinical trial
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine…
NCT00318955 · Hospira, now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00318955 |
|---|---|
| Title | Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients |
| Official title | A Post-Marketing, Open-Label, Randomized, Comparative Study Comparing the Usefulness of Dexmedetomidine at the Time of Extubation and Post Extubation Period to Other Sedative Management in Post-Operative Patients |
| Lead sponsor | Hospira, now a wholly owned subsidiary of Pfizer, Industry |
| Collaborators | Maruishi Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Conscious Sedation |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Propofol |
| Enrollment | 85 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Mar 20, 2017 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: